Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FAXX8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,178
Award facts
- Contract value 100% obligated
- $3,178.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,178.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 2.5 mg/0.5 mL pens on May 30, 2025, with completion targeted for June 2, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order represents a non-competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999.99 billion global pharmaceutical supply vehicle valued through December 2026. The IDC serves as the primary mechanism through which the Defense Logistics Agency procures pharmaceutical products and medical supplies to support military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a substantial federal contract portfolio focused on supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's demonstrated capability to serve federal medical procurement needs through competitive contracting and its extensive experience fulfilling DLA requirements position it as a critical vendor supporting the Defense Health Agency and other federal healthcare systems. This specific delivery order for Zepbound, a diabetes and weight management medication, aligns with the broader pharmaceutical supply requirements of military and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DB25FAXX8?
SPE2DB25FAXX8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 30, 2025.
How much is contract SPE2DB25FAXX8 worth?
The government has obligated $3,178 on SPE2DB25FAXX8.
Is contract SPE2DB25FAXX8 an order under another contract?
Yes. SPE2DB25FAXX8 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FAXX8 competed?
The extent of competition for SPE2DB25FAXX8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award